Location History:
- Cambridge, MA (US) (2018 - 2024)
- San Mateo, CA (US) (2022 - 2024)
Company Filing History:
Years Active: 2018-2025
Title: Inventor Profile: Hariharan Jayaram
Introduction
Hariharan Jayaram is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of cancer immunotherapy. With an impressive portfolio of 12 patents, he has made strides in genetic engineering that aim to enhance treatment options for patients.
Latest Patents
Among his latest innovations are two notable patents: "CRISPR/Cpf1-related methods, compositions, and components for cancer immunotherapy," which focuses on using CRISPR technology for cancer treatment, and "Assessing nuclease cleavage," detailing systems and methods for analyzing the cleavage profiles of nucleases.
Career Highlights
Hariharan currently operates at Editas Medicine, Inc., a leading organization in the realm of genomic medicine. His research and innovations aim to push the boundaries of how gene editing can be utilized in therapeutic applications, particularly in oncology.
Collaborations
At Editas Medicine, Hariharan collaborates closely with fellow inventor Ari E. Friedland. This teamwork fosters a rich environment of innovation and knowledge exchange, significantly augmenting the research and development process within the company.
Conclusion
In summary, Hariharan Jayaram stands out as a notable inventor in the biotechnology sector, specifically in cancer therapy through his pioneering work with CRISPR technology. His contributions not only reflect his expertise but also hold the potential to transform treatment paradigms in oncology for the future.